MedPath

Bariatric Surgery and Exercise Interventions: Effects on Muscle

Not Applicable
Recruiting
Conditions
Bariatric Surgery Candidate
Obesity
Interventions
Other: Resistance Exercise Therapy
Registration Number
NCT05569785
Lead Sponsor
University of Nottingham
Brief Summary

The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.

Detailed Description

A single-centre feasibility research programme based at the Royal Derby Hospital centre of the University of Nottingham. This is an exploratory and feasibility study. Muscle structure and function of 12 patients will be assessed before bariatric surgery and at 6 weeks, and then 10 weeks, after surgery. After 6 weeks, participants will be randomised into two groups. Group 1 will undergo a 4 week Resistance Exercise Training (RET). Group 2 will undergo standard care procedure. The total duration of programme we are aiming for is 13-14 weeks prior to bariatric surgery and exercise intervention for 4 weeks after bariatric surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Obese adults (BMI greater than or equal to 35 kg/m2)
  • Age range 18-70 years old
  • Scheduled for RYGB surgery or sleeve gastrectomy surgery.
  • Ability to give informed consent
Exclusion Criteria
  • Patients who are not fit or not suitable for RYGB or Sleeve Gastrectomy as per Tier 4 Bariatric Surgery MDT.
  • For those high-risk patients who are fast tracked to surgery, we will exclude patients with a NYHA >3 or 4 heart failure status and those with end stage renal failure.
  • BMI greater than or equal to 60

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1 Resistance Exercise Therapy FeasibilityResistance Exercise TherapyOne group who have been randomised to receive 4 weeks of Resistance Exercise Therapy to explore the feasibility of introducing such a programme in the bariatric population.
Primary Outcome Measures
NameTimeMethod
Assessment of percentage of patients who were retained throughout the intervention arm of the studyTotal duration of study per participant is expected to be 13 to 14 weeks

To be measured as percentage.

Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use.Total duration of study per participant is expected to be 13 to 14 weeks

This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study.

To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness.Total duration of study per participant is expected to be 13 to 14 weeks

This will be assessed using muscle ultrasound and units (mm)

To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2)Total duration of study per participant is expected to be 13 to 14 weeks

This will be assessed using muscle ultrasound

Assessment of number of patients who were recruited to the studyTotal duration of study per participant is expected to be 13 to 14 weeks

This assessment will be measured as a simple numeric value

Secondary Outcome Measures
NameTimeMethod
Fasting glucoseTotal duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface.

These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be mmol .

Skeletal muscle architecture (fibre length)Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day

An ultrasound scan will be used for the purpose of this measurement. Units (mm).

Muscle fatigability (maximum voluntary contractions)Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days.

This is the maximal force-generating capacity of a muscle or group of muscles

Balance using the Timed Up and Go (TUG) testTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

As part of the Short Physical Performance Battery Test

Balance in Gait and Motion testingTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

As part of the Short Physical Performance Battery Test

Hand grip strengthTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

The purpose of the handgrip strength test is to measure the maximum isometric strength of the hand and forearm muscles

Lean body mass using BIA and D3 creatineTotal duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later..

These are stable biomarkers that have been previously used in research. It acts in the body as creatine, which is a naturally occurring substance.

Motor control in force trackingTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

As part of the Short Physical Performance Battery Test

Predicted maximum oxygen consumption (VO2 max) in step box testTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

As part of the Short Physical Performance Battery Test

Skin fold and body circumference measurementsTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

To assess for any interval change

Quality of life measurements using IPAQ questionnaireTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

Questionnaires are performed to standardise the assessment of quality of life from the patient perspective. IPAQ questionnaire contains open-ended questions surrounding individuals' last 7-day recall of physical activity

Skeletal muscle architecture (pennation angle)Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

An ultrasound scan will be used for the purpose of this measurement, units will be in degrees.

insulin resistance (HOMA-IR)Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be nmol/L.

Quality of life measurements using SF-36 questionnaireTotal duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

Questionnaires are performed to standardise the assessment of quality of life from the patient perspective.This questionnaire uses a likert scale as means of assessment.

Trial Locations

Locations (1)

COMAP

🇬🇧

Derby, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath